A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05704738

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

532 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-20

Study Completion Date

2025-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A: Dose 1

Part 1 (Initial Period); Week 0 to Week 24: Rocatinlimab Dose 1 every 4 weeks (Q4W) for 24 weeks with loading dose at Week 2 (+ topical corticosteroids (TCS)/ topical calcineurin inhibitor (TCI) if within combination therapy cohort).

Part 2 (Maintenance Period); Week 24 to Week 52: Part 1 Responders will be rerandomised at Week 24 to Rocatinlimab Dose 1 Q4W or every 8 weeks (Q8W) for 28 weeks (+ TCS/TCI if within combination therapy cohort).

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Subcutaneous (SC) injection

Arm B: Dose 2

Part 1 (Initial Period); Week 0 to Week 24: Rocatinlimab Dose 2 Q4W for 24 weeks with loading dose at Week 2 (+TCS/TCI if within combination therapy cohort).

Part 2 (Maintenance Period); Week 24 to Week 52: Part 1 Responders will be rerandomised at Week 24 to Rocatinlimab Dose 2 Q4W or Q8W for 28 weeks (with TCS/TCI if within combination therapy cohort).

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Subcutaneous (SC) injection

Arm C: Placebo

Part 1 (Initial Period); Week 0 to Week 24: Placebo Q4W for 24 weeks with loading dose at Week 2 (+TCS/TCI if within combination therapy cohort).

Part 2 (Maintenance Period); Week 24 to Week 52: Part 1 Responders will be reassigned at Week 24 with Placebo Q4W for 28 weeks (with TCS/TCI if within combination therapy cohort).

Group Type EXPERIMENTAL

Placebo

Intervention Type DRUG

SC injection

Arm D: Open-Label Dose 1

Part 2; Week 24 to Week 52: Part 1 Non-Responders will be reassigned at Week 24 with Rocatinlimab Open-label Dose 1 Q4W for 28 weeks (with TCS/TCI if within combination therapy cohort). Participants in Arms A, B or C Maintenance Period will be reassigned with Rocatinlimab Open-label Dose 1 Q4W (with TCS/TCI if within combination therapy cohort) upon relapse after Week 24.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Subcutaneous (SC) injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rocatinlimab

Subcutaneous (SC) injection

Intervention Type DRUG

Placebo

SC injection

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 451

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 12 to \< 18 years at Day 1.
* Diagnosis of AD (according to American Academy of Dermatology Consensus Criteria \[Eichenfield et al, 2014\]) that has been present for at least 12 months before signing of informed consent.
* Body weight ≥ 40 kg at screening.
* History of inadequate response to TCS of medium to higher potency (with or without TCI).
* EASI score ≥ 12 at initial screening.
* EASI score ≥ 16 at Day 1.
* vIGA-AD score ≥ 3.
* ≥10% body surface area of AD involvement.
* Worst pruritus NRS ≥ 4.

Exclusion Criteria

* Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1.
* Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:

1. Systemic corticosteroids
2. Non-biologic, non-targeted systemic immunosuppressants
3. Phototherapy
4. Oral or Topical Janus kinase inhibitors
* Treatment with any of the following medications or therapies within 1 week, prior to Day 1:

1. TCS of any potency
2. TCI
3. Topical phosphodiesterase 4 inhibitors
4. Other topical immunosuppressive agents
Minimum Eligible Age

12 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cahaba Dermatology and Skin Health Center

Birmingham, Alabama, United States

Site Status

AllerVie Clinical Research- Cullman

Cullman, Alabama, United States

Site Status

Eclipse Clinical Research

Tucson, Arizona, United States

Site Status

Arkansas Research Trials, LLC

North Little Rock, Arkansas, United States

Site Status

Center for Dermatology Clinical Research Inc

Fremont, California, United States

Site Status

Doc1 Healthcare Systems Incorporated

Fullerton, California, United States

Site Status

Axon Clinical Research

Inglewood, California, United States

Site Status

Avance Clinical Trials

Laguna Niguel, California, United States

Site Status

Cura Clinical Research

Palmdale, California, United States

Site Status

Integrative Skin Science and Research

Sacramento, California, United States

Site Status

University of California at Davis Medical Center

Sacramento, California, United States

Site Status

Allergy and Asthma Medical Group and Research Center

San Diego, California, United States

Site Status

University of California at San Diego Rady Childrens Hospital San Diego

San Diego, California, United States

Site Status

Clinical Science Institute

Santa Monica, California, United States

Site Status

Cura Clinical Research Sherman Oaks

Sherman Oaks, California, United States

Site Status

Velocity Clinical Research - Denver

Denver, Colorado, United States

Site Status

Childrens National Medical Center

Washington D.C., District of Columbia, United States

Site Status

Clinical Research of Brandon

Brandon, Florida, United States

Site Status

Academic Alliance in Dermatology - Saint Petersburg Office

Clearwater, Florida, United States

Site Status

Corazon United States of America, LLC doing business as Life Clinical Trials

Coral Springs, Florida, United States

Site Status

Palm Beach Dermatology Group

Delray Beach, Florida, United States

Site Status

Direct Helpers Research Center

Hialeah, Florida, United States

Site Status

Glick Skin Institute

Margate, Florida, United States

Site Status

Miami Clinical Research

Miami, Florida, United States

Site Status

ara Professionals Limited Liability Corporation

Miami, Florida, United States

Site Status

Deluxe Health Care LLC

Miami Lakes, Florida, United States

Site Status

Savin Medical Group LLC

Miami Lakes, Florida, United States

Site Status

Angels Clinical Research Institute

Miami Lakes, Florida, United States

Site Status

Optimal Research Sites, LLC

Orange City, Florida, United States

Site Status

Clinical Associates of Orlando Limited Liability Company

Orlando, Florida, United States

Site Status

Clinical Research Investments

Orlando, Florida, United States

Site Status

University of South Florida

Tampa, Florida, United States

Site Status

Centricity Research Columbus

Columbus, Georgia, United States

Site Status

Advanced Medical Research PC

Sandy Springs, Georgia, United States

Site Status

Divine Dermatology and Aesthetics

Savannah, Georgia, United States

Site Status

McIntosh Clinic PC

Thomasville, Georgia, United States

Site Status

Treasure Valley Medical Research

Boise, Idaho, United States

Site Status

Velocity Clinical Research - Boise

Meridian, Idaho, United States

Site Status

NorthShore University HealthSystem Clinical Trials Center

Skokie, Illinois, United States

Site Status

Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, United States

Site Status

Southern Indiana Clinical Trials

New Albany, Indiana, United States

Site Status

The Indiana Clinical Trials Center PC

Plainfield, Indiana, United States

Site Status

Equity Medical

Bowling Green, Kentucky, United States

Site Status

Kentucky Advanced Medical Research LLC

Murray, Kentucky, United States

Site Status

Industrial Medicine Associates Clinical Research Advanced Dermatology Care

Monroe, Louisiana, United States

Site Status

Aesthetic and Dermatology Center

Rockville, Maryland, United States

Site Status

Derm Associates, PC

Rockville, Maryland, United States

Site Status

Oakland Hills Dermatology

Auburn Hills, Michigan, United States

Site Status

Henry Ford Health System

Detroit, Michigan, United States

Site Status

Onyx Clinical Research

Flint, Michigan, United States

Site Status

MediSearch Clinical Trials

Saint Joseph, Missouri, United States

Site Status

Saint Louis University

St Louis, Missouri, United States

Site Status

Somnos Clinical Research

Lincoln, Nebraska, United States

Site Status

Skin Cancer and Dermatology Institute

Reno, Nevada, United States

Site Status

Allcutis Research

Portsmouth, New Hampshire, United States

Site Status

The Dermatology Center of New Jersey

Bridgewater, New Jersey, United States

Site Status

University of New Mexico

Albuquerque, New Mexico, United States

Site Status

Ace Clinical Trials

Brooklyn, New York, United States

Site Status

Empire Dermatology

East Syracuse, New York, United States

Site Status

Smart Medical Research Inc

Jackson Heights, New York, United States

Site Status

Forest Hills Dermatology Group

Kew Gardens, New York, United States

Site Status

Pioneer Clinical Research New York

New York, New York, United States

Site Status

Cornell University - Weill Cornell Medicine

New York, New York, United States

Site Status

Rochester Clinical Research

Rochester, New York, United States

Site Status

Yeshiva University - Montefiore Medical Center

The Bronx, New York, United States

Site Status

Duke South Durham

Durham, North Carolina, United States

Site Status

Optima Research

Boardman, Ohio, United States

Site Status

Apex Clinical Research Center LLC

Mayfield Heights, Ohio, United States

Site Status

Epic Medical Research - Oklahoma

Chickasha, Oklahoma, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Dermatology and Aesthetics of Oklahoma

Oklahoma City, Oklahoma, United States

Site Status

Dermatology Research Center of Oklahoma, PLLC

Tulsa, Oklahoma, United States

Site Status

Essential Medical Research LLC

Tulsa, Oklahoma, United States

Site Status

Velocity Clinical Research - Grants Pass

Grants Pass, Oregon, United States

Site Status

Oregon Health and Science University

Portland, Oregon, United States

Site Status

Paddington Testing Company Inc

Philadelphia, Pennsylvania, United States

Site Status

Rhode Island Hospital, Lifespan

Providence, Rhode Island, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

National Allergy and Asthma Research, LLC

North Charleston, South Carolina, United States

Site Status

Coastal Pediatric Research

Summerville, South Carolina, United States

Site Status

HealthStar Physicians Dermatology

Morristown, Tennessee, United States

Site Status

The University of Texas Health Science Center at Houston

Bellaire, Texas, United States

Site Status

US Dermatology Partners Cedar Park

Cedar Park, Texas, United States

Site Status

Studies in Dermatology LLC

Cypress, Texas, United States

Site Status

MedCare Pharma - Houston

Houston, Texas, United States

Site Status

Tranquil Clinical Research

Houston, Texas, United States

Site Status

Sante Clinical Research

Kerrville, Texas, United States

Site Status

Long and Harris Dermatology

Lubbock, Texas, United States

Site Status

Sms Clinical Research Limited Liability Company

Mesquite, Texas, United States

Site Status

Sienna Dermatology Research

Missouri City, Texas, United States

Site Status

Texas Dermatology and Laser Specialists

San Antonio, Texas, United States

Site Status

Epiphany Dermatology

Southlake, Texas, United States

Site Status

Pioneer Research Solutions

Sugar Land, Texas, United States

Site Status

Tanner Clinic

Murray, Utah, United States

Site Status

Dermatology Research of Utah, dba Providence Dermatology

Providence, Utah, United States

Site Status

Jordan Valley Dermatology Center

South Jordan, Utah, United States

Site Status

Maria M Ona MD PC

Franklin, Virginia, United States

Site Status

Northwest Clinical Research Center

Bellevue, Washington, United States

Site Status

Hopital Erasme

Brussels, , Belgium

Site Status

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege - Sart Tilman

Liège, , Belgium

Site Status

Dermatologie Maldegem

Maldegem, , Belgium

Site Status

Centro do Diagnostico e Pesquisa da Osteoporose do Espirito Santo

Vitória, Espírito Santo, Brazil

Site Status

Clinica Instituto Bahiano de Imunoterapia - Medicina, Reumatologia e Dermatologia ltda

Salvador, Estado de Bahia, Brazil

Site Status

Centro de Pesquisa Clínica da Universidade de Belo Horizonte - Unibh

Belo Horizonte, Minas Gerais, Brazil

Site Status

Irmandade da Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Cecip Centro Est Clin Int Paulista

Jaú, São Paulo, Brazil

Site Status

Le Plume Dermatologia- Clinica de Dermatologia Dra Beatriz Elias Eirelli

Ribeirão Preto, São Paulo, Brazil

Site Status

Hospital de Base de Sao Jose do Rio Preto

São José do Rio Preto, São Paulo, Brazil

Site Status

Instituto Pesquisa e Ensino em Saúde Infantil

São Paulo, São Paulo, Brazil

Site Status

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, Brazil

Site Status

IBPClin Instituto Brasil de Pesquisa Clinica

Rio de Janeiro, , Brazil

Site Status

Rejuvenation Dermatology Laser Calgary North

Calgary, Alberta, Canada

Site Status

Lynderm Research Inc

Markham, Ontario, Canada

Site Status

Dr SK Siddha Medicine Professional Corporation

Newmarket, Ontario, Canada

Site Status

Allergy Research Canada Incorporated

Niagara Falls, Ontario, Canada

Site Status

XLR8 Medical Research, Incorporated

Windsor, Ontario, Canada

Site Status

Skinsense Medical Research

Saskatoon, Saskatchewan, Canada

Site Status

Centro Dermatologico Dermisur

Osorno, , Chile

Site Status

Centro Medico Skinmed Spa

Santiago, , Chile

Site Status

Clinica Dermacross SA

Santiago, , Chile

Site Status

Fundacion Innovacion Cardiovascular

Santiago, , Chile

Site Status

Centro Internacional de Estudios Clinicos

Santiago, , Chile

Site Status

Childrens Hospital Capital Institute of Pediatrics

Beijing, Beijing Municipality, China

Site Status

Peking University Peoples Hospital

Beijing, Beijing Municipality, China

Site Status

Beijing Childrens Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

Childrens Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Site Status

The First Affiliated Hospital Sun-Yat Sen University

Guangzhou, Guangdong, China

Site Status

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China

Site Status

Sun Yat-sen Memorial Hospital Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

Nanyang First Peoples Hospital

Nanyang, Henan, China

Site Status

The Central Hospital of Wuhan

Wuhan, Hubei, China

Site Status

Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, Hubei, China

Site Status

Jiangyin Hospital of Traditional Chinese Medicine

Jiangyin, Jiangsu, China

Site Status

The First Bethune Hospital of Jilin University

Changchun, Jilin, China

Site Status

Dalian Women and Childrens Medical Group

Dalian, Liaoning, China

Site Status

General Hospital of Ningxia Medical University

Yinchuan, Ningxia, China

Site Status

Shanghai Skin Disease Hospital

Shanghai, Shanghai Municipality, China

Site Status

Chengdu Second Peoples Hospital

Chengdu, Sichuan, China

Site Status

Suining Central Hospital

Suining, Sichuan, China

Site Status

Kunming Childrens Hospital

Kunming, Yunnan, China

Site Status

Affiliated Hangzhou First Peoples Hospital School of Medicine Westlake University

Hangzhou, Zhejiang, China

Site Status

Ningbo NO 2 Hospital

Ningbo, Zhejiang, China

Site Status

Taizhou Central Hospital

Taizhou, Zhejiang, China

Site Status

Hunan Childrens Hospital

Changsha, , China

Site Status

Shenzhen Childrens Hospital

Shenzhen, , China

Site Status

Special Hospital for Medical Rehabilitation Naftalan

Ivanić-Grad, , Croatia

Site Status

University Hospital Centre Osijek

Osijek, , Croatia

Site Status

Children s Hospital Zagreb

Zagreb, , Croatia

Site Status

Sestre milosrdnice University Hospital Center

Zagreb, , Croatia

Site Status

University Hospital Centre Zagreb

Zagreb, , Croatia

Site Status

Hopital Prive d Antony

Antony, , France

Site Status

Centre Hospitalier Regional Universitaire Brest Hopital Morvan

Brest, , France

Site Status

Hôpital Saint-Joseph

Marseille, , France

Site Status

Centre Hospitalier Universitaire de Nantes Hôtel Dieu

Nantes, , France

Site Status

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou

Rennes, , France

Site Status

Centre Hospitalier Universitaire de Rouen - Hôpital Charles Nicolle

Rouen, , France

Site Status

Centre Hospitalier Universitaire de Toulouse, Hopital Larrey

Toulouse, , France

Site Status

Fachklinik Bad Bentheim

Bad Bentheim, , Germany

Site Status

Universitaetsklinikum Bonn

Bonn, , Germany

Site Status

Rosenpark Research GmbH

Darmstadt, , Germany

Site Status

Universitaetsklinikum Dresden

Dresden, , Germany

Site Status

Universitaetsklinikum Erlangen

Erlangen, , Germany

Site Status

Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universitaet Frankfurt am Main

Frankfurt am Main, , Germany

Site Status

Velocity Clinical Research

Leipzig, , Germany

Site Status

Johannes Gutenberg Universitaet Mainz

Mainz, , Germany

Site Status

Athens Naval Hospital

Athens, , Greece

Site Status

Athens General Childrens Hospital Panagioti And Aglaia Kyriakou

Athens, , Greece

Site Status

Thoracic General Hospital Of Athens Sotiria

Athens, , Greece

Site Status

Ippokratio General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Clinexpert Kft

Budapest, , Hungary

Site Status

Derma-B Egeszsegugyi es Szolgaltato Kft

Debrecen, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Somogy Varmegyei Kaposi Mor Oktato Korhaz

Kaposvár, , Hungary

Site Status

Soroka Medical Center

Bear Sheva, , Israel

Site Status

Sheba Medical Center

Ramat Gan, , Israel

Site Status

Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Milan, , Italy

Site Status

Azienda Ospedaliera Universitaria Luigi Vanvitelli

Napoli, , Italy

Site Status

Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia

Perugia, , Italy

Site Status

Presidio Molinette Azienda Ospedaliera Citta della Salute e della Scienza di Torino

Torino, , Italy

Site Status

Central Clinic

Nagoya, Aichi-ken, Japan

Site Status

Miyata Dermatology Clinic

Matsudo-shi, Chiba, Japan

Site Status

Matsuo Clinic

Fukuoka, Fukuoka, Japan

Site Status

Asahikawa City Hospital

Asahikawa-shi, Hokkaido, Japan

Site Status

Takagi Dermatological Clinic

Obihiro-shi, Hokkaido, Japan

Site Status

Yoshimura Child Clinic

Akashi-shi, Hyōgo, Japan

Site Status

Katahira Dermatology Urology Clinic

Kagoshima, Kagoshima-ken, Japan

Site Status

Nomura Dermatology Clinic

Yokohama, Kanagawa, Japan

Site Status

Yokohama City Minato Red Cross Hospital

Yokohama, Kanagawa, Japan

Site Status

Jouzan Hihuka Hinyoukika Clinic

Kumamoto, Kumamoto, Japan

Site Status

Suizenji Dermatology Clinic

Kumamoto, Kumamoto, Japan

Site Status

Yoshioka Dermatology Clinic

Neyagawa, Osaka, Japan

Site Status

Dermatology and Ophthalmology Kume Clinic

Sakai-shi, Osaka, Japan

Site Status

Hamamatsu University Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Naoko Dermatology Clinic

Setagaya-ku, Tokyo, Japan

Site Status

NTT Medical Center Tokyo

Shinagawa-ku, Tokyo, Japan

Site Status

Phylasis Clinicas Research Toluca

Toluca, , Mexico

Site Status

Uniwersyteckie Centrum Kliniczne

Gdansk, , Poland

Site Status

AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy

Gdansk, , Poland

Site Status

GynCentrum Sp zoo NZOZ Holsamed

Katowice, , Poland

Site Status

Centrum Medyczne Angelius Provita

Katowice, , Poland

Site Status

Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski Pawel Brzewski SpCywilna

Krakow, , Poland

Site Status

Diamond Clinic Spolka z Ograniczona Odpowiedzialnoscia Diamond Medical Center

Krakow, , Poland

Site Status

AppleTreeClinics Network Spzoo

Lodz, , Poland

Site Status

Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne

Lodz, , Poland

Site Status

Clinical Best Solutions Sp zoo Spolka Komandytowa

Lublin, , Poland

Site Status

Centrum Zdrowia Dziecka i Rodziny Im Jana Pawla II w Sosnowcu Osrodek Badan Klinicznych

Sosnowiec, , Poland

Site Status

Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo

Tarnów, , Poland

Site Status

Klinika Osipowicz and Turkowski Sp zoo

Warsaw, , Poland

Site Status

High Med Przychodnia Specjalistyczna

Warsaw, , Poland

Site Status

Klinika Ambroziak Dermatologia

Warsaw, , Poland

Site Status

Royalderm Agnieszka Nawrocka

Warsaw, , Poland

Site Status

Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych

Wroclaw, , Poland

Site Status

Clinical Research of Puerto Rico

San Juan, , Puerto Rico

Site Status

Gcm Medical Group, Psc

San Juan, , Puerto Rico

Site Status

Dr Leventer Centre Clinica Dermatologie Bucuresti

Bucharest, , Romania

Site Status

Derma Cluj

Cluj-Napoca, , Romania

Site Status

Institutul Regional de Gastroenterologie si Hepatologie Prof Dr Octavian Fodor

Cluj-Napoca, , Romania

Site Status

Korea University Ansan Hospital

Ansansi, Gyeonggido, , South Korea

Site Status

Nowon Eulji Medical Center, Eulji University

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

National Medical Center

Seoul, , South Korea

Site Status

Kyung Hee University Hospital at Gangdong

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St Marys Hospital

Seoul, , South Korea

Site Status

Chung-Ang University Hospital

Seoul, , South Korea

Site Status

Hallym University Kangnam Sacred Heart Hospital

Seoul, , South Korea

Site Status

Ewha Womans University Seoul Hospital

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, Catalonia, Spain

Site Status

Hospital Sant Joan de Deu

Esplugues de Llobregat, Catalonia, Spain

Site Status

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Site Status

Hospital General Universitario Gregorio Maranon

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Linkou Chang Gung Memorial Hospital

Taoyuan District, , Taiwan

Site Status

King Chulalongkorn Memorial Hospital

Bangkok, , Thailand

Site Status

Siriraj Hospital

Bangkok, , Thailand

Site Status

Maharaj Nakorn Chiang Mai Hospital

Chiang Mai, , Thailand

Site Status

Thammasat University Hospital

Pathum Thani, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Brazil Canada Chile China Croatia France Germany Greece Hungary Israel Italy Japan Mexico Poland Puerto Rico Romania South Korea Spain Taiwan Thailand

References

Explore related publications, articles, or registry entries linked to this study.

Guttman-Yassky E, Simpson E, Bissonnette R, Eichenfield LF, Kabashima K, Luna PC, Hercogova JT, Spelman L, Worm M, Esfandiari E, Arai T, Mano H, Charuworn P, Wang A, Kricorian G. ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 2025 Feb;17(2):83-94. doi: 10.1080/1750743X.2025.2464528. Epub 2025 Feb 26.

Reference Type BACKGROUND
PMID: 40012373 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-501586-50

Identifier Type: OTHER

Identifier Source: secondary_id

20210145

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.